Telocyte

Telocyte is a private U.S. biotechnology company focused on developing telomerase-based therapeutics intended to reverse cellular aging and treat Alzheimer's disease. The company positions its approach as an epigenomic strategy designed to reset age-related gene-expression changes rather than simply addressing downstream amyloid or tau pathology. Its lead effort appears to be a telomerase gene therapy program for Alzheimer's disease and related neurodegenerative conditions, with the company describing plans for FDA-sponsored human trials but no clearly documented active clinical trials. Telocyte also presents a broader vision around age-related disease reversal and has referenced the use of artificial intelligence and digital health tools in its platform strategy. Overall, it is an early-stage longevity-focused neurodegeneration biotech centered on telomere biology and telomerase activation.